Autopsy report · NCT01422096

Effect of Short Term Ovarian Suppression on Androgen Overproduction in Overweight Girls With Androgen Excess

“The study team decided not to pursue this study.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Early Phase 1

Sponsor

University of Virginia

Sponsor type

University, hospital or other

Conditions

Hyperandrogenemia; Obesity; Polycystic Ovary Syndrome

Interventions

Leuprolide

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• A Coach-Guided Online Acceptance and Commitment Therapy (ACT) Intervention for Stroke Survivors
  “The research team decided not to implement this study.” (89% match in meaning)
• Activity of Pre-Osteoclasts and Osteoclasts Over Time in Postmenopausal Women Treated With Denosumab or Zoledronic Acid
  “The Investigator decided not to pursue this study.” (85% match in meaning)
• Assessment of Thoughts and Feelings Occurring During and After a Meal
  “Decision was made not to start the study before it was initiated.” (79% match in meaning)
• To Compare the Efficacy of I.V 200 mg Iron Sucrose and 500 mg Iron Sucrose to Treat Anemia in Pregnancy
  “The investigators decided not to proceed with this study” (77% match in meaning)
• Analgesic Efficacy of Intravenous Lidocaine for Postoperative Pain Following Adult Spine Surgery
  “Did not have the research staff necessary to follow through with this study.” (76% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.